The demand for wound care products in Brazil is showing steady growth. According to a market report, the Brazilian wound care market is expected to reach USD 545.1 million by 2030, with a compound annual growth rate (CAGR) of 3.6%. The main drivers of this growth are improvements in healthcare infrastructure and the rising incidence...Read More
The European Wound Management Association (EWMA) Annual Conference is one of the most prominent international events in the field of wound care, bringing together clinicians, researchers, and industry professionals to share the latest developments in wound management, clinical practices, and innovation.Read More
Oneness received the notification today from the agent that our product has passed the Brazilian Good Manufacturing Practice (B-GMP) certification according to the Brazilian Official Announcement (DOU) issued by ANVISA.Read More
The advanced wound care market in the Middle East is showing stable growth, primarily driven by the increasing number of chronic wound cases, particularly DFU. Data indicates that the advanced wound care market in the Middle East is expected to reach USD 4.8 billion by 2028, with a compound annual growth rate (CAGR) of 5.8%....Read More
Oneness Listed in the S&P Global Sustainability Yearbook for the Third Consecutive Year, Ranking Among the Top 10 in the Global "Pharmaceuticals Industry" for 2025Read More
Oneness has received notification from the Notified Body, confirming that we comply with the MDSAP (Medical Device Single Audit Program) quality management system standards. The MDSAP certificate has been issued with the certificate number: MDSAP 803792Read More
Oneness Biotech Co., Ltd., had been granted with MDSAP (Medical Device Single Audit Program) certification for medical device quality management system.Read More
To effectively prevent the occurrence of foot ulcers, it is essential to engage in proper foot care, undergo regular examinations, and address arterial hardening.Read More
According to the International Diabetes Federation (IDF), the population of Saudi diabetic patients are more than 4 million people. The number of DFU patients is approximately 500,000. Current treatments in Saudi Arabia are mostly traditional remedies, and the incidences of ulcer infection and amputation are relatively high.Read More
